Vaccination anti-COVID-19 chez les patients dialysés et transplantés rénaux

Patients with end stage renal disease, including dialysis and kidney transplantation, have a high risk of severe COVID-19. In these populations, post-COVID-19 humoral response is prolonged until 6 months post-infection. However, post-vaccination humoral responses are frequently weak even when positi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakhi, Hamza, Chavarot, Nathalie, Attias, Philippe, El Karoui, Khalil, Anglicheau, Dany
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Société francophone de néphrologie, dialyse et transplantation. Published by Elsevier Masson SAS. 2021
Materias:
Mise Au Point
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245347/
https://www.ncbi.nlm.nih.gov/pubmed/34305020
http://dx.doi.org/10.1016/j.nephro.2021.06.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245347/
https://www.ncbi.nlm.nih.gov/pubmed/34305020
http://dx.doi.org/10.1016/j.nephro.2021.06.005

Ejemplares similares